Market Cap

CRISPR Therapeutics AG Market Capitalization:

$4.51 Billion

USD as of July 1, 2025

business CRISPR Therapeutics AG Company Profile

CRISPR Therapeutics AG Main Stock Listing

NASDAQ: CRSP

Market Capitalization History of CRISPR Therapeutics AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of CRISPR Therapeutics AG market cap

Date Market Cap YoY Change
Jan. 1, 2025 $3.78 B -21.66%
Jan. 1, 2024 $4.82 B 29.69%
Jan. 1, 2023 $3.72 B -25.95%
Jan. 1, 2022 $5.02 B -61.53%
Jan. 1, 2021 $13.04 B 218.96%
Jan. 1, 2020 $4.09 B 60.19%
Jan. 1, 2019 $2.55 B -17.44%
Jan. 1, 2018 $3.09 B 121.30%
Jan. 1, 2017 $1.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

CRISPR Therapeutics AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

CRISPR Therapeutics AG has the following listings and related stock indices.


Stock: NASDAQ: CRSP

Stock: BMV: CRSPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.